The effects of multiple chronic conditions on hospitalization costs and utilization for ambulatory care sensitive conditions in the United States: a nationally representative cross-sectional study by unknown
RESEARCH ARTICLE Open Access
The effects of multiple chronic conditions
on hospitalization costs and utilization for
ambulatory care sensitive conditions in the
United States: a nationally representative
cross-sectional study
Halcyon G. Skinner1*, Rosanna Coffey2, Jenna Jones2, Kevin C. Heslin3 and Ernest Moy3
Abstract
Background: The presence of multiple chronic conditions (MCCs) complicates inpatient hospital care, leading to
higher costs and utilization. Multimorbidity also complicates primary care, increasing the likelihood of
hospitalization for ambulatory care sensitive conditions. The purpose of this study was to evaluate how MCCs relate
to inpatient hospitalization costs and utilization for ambulatory care sensitive conditions.
Methods: The 2012 Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization Project
(HCUP) State Inpatient Databases (SID) provided data to carry out a cross-sectional analysis of 1.43 million claims
related to potentially preventable hospitalizations classified by the AHRQ Prevention Quality Indicator (PQI)
composites. Categories of MCCs (0–1, 2–3, 4–5, and 6+) were examined in sets of acute, chronic, and overall PQIs.
Multivariate models determined associations between categories of MCCs and 1) inpatient costs per stay, 2)
inpatient costs per day, and 3) length of inpatient hospitalization. Negative binomial was used to model costs per
stay and costs per day.
Results: The most common category observed was 2 or 3 chronic conditions (37.8 % of patients), followed by 4 or
5 chronic conditions (30.1 % of patients) and by 6+ chronic conditions (10.1 %). Compared with costs for patients
with 0 or 1 chronic condition, hospitalization costs per stay for overall ambulatory care sensitive conditions were
19 % higher for those with 2 or 3 (95 % confidence interval [CI] 1.19–1.20), 32 % higher for those with 4 or 5 (95 %
CI 1.31–1.32), and 31 % higher (95 % CI 1.30–3.32) for those with 6+ conditions. Acute condition stays were 11 %
longer when 2 or 3 chronic conditions were present (95 % CI 1.11–1.12), 21 % longer when 4 or 5 were present
(95 % CI 1.20–1.22), and 27 % longer when 6+ were present (95 % CI 1.26–1.28) compared with those with 0 or 1
chronic condition. Similar results were seen within chronic conditions. Associations between MCCs and total costs
were driven by longer stays among those with more chronic conditions rather than by higher costs per day.
Conclusions: The presence of MCCs increased inpatient costs for ambulatory care sensitive conditions via longer
hospital stays.
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Background
In international comparisons, The U.S. health care sys-
tem ranks best in the provision of preventive and
patient-centered care [1], but lags in efficiency and ac-
cess. The top 1 % of U.S. patients’ utilization accounts
for 23 % of health care expenditures [2]. Many of these
high health care users are diagnosed with more than one
condition and may have complicated ambulatory care
needs. Among Americans, 25 % have multimorbidity,
otherwise known as a multiple chronic conditions
(MCC) defined as two or more concurrent chronic con-
ditions [3], and 68–80 % of people aged 65 years or older
have MCC [4, 5].
Currently, more than two-thirds of all hospital dis-
charges in the United States are for individuals with
MCCs [6]. The U.S. Department of Health and Human
Services (HHS) has identified the prevalence of MCCs
and associated consequences in the United States as a
key health care concern [7]. Presence of MCCs has been
shown to complicate inpatient hospital care [8], leading
to higher costs and utilization [6, 9–11]. For example, a
1999 study of older adults in the United States found
that, on average, Medicare paid over $13,000 more each
year for medical care for beneficiaries with more than 3
chronic conditions, than those with none [11]. That
same study found that, per capita, the cost per benefi-
ciary with no chronic conditions was less than $1000. At
the same time, multimorbidity complicates ambulatory
care, which can increase the likelihood of hospitalization
for potentially preventable conditions [12–14].
The U.S. Department of Health and Human Services,
is focusing on people with MCCs as one target for im-
proving care for vulnerable populations. The HHS initia-
tive on MCCs aims to assess the burden of MCCs on
the health of the population and to evaluate the role of
MCCs in health care utilization, quality, and costs. The
goal is to inform future health policies to improve care
and reduce cost [15]. From the 2012 implementation of
the HHS Strategic Framework on Multiple Chronic
Conditions, HHS is focusing on dissemination of data
and advancement of quality measures [7].
The Agency for Healthcare Research and Quality
(AHRQ) Prevention Quality Indicators (PQIs) are a set
of measures designed to quantify the occurrence of po-
tentially preventable hospitalizations among ambulatory
care sensitive conditions. These measures of population
health are useful for tracking trends in hospitalization
for conditions linked to the quality of ambulatory care.
In all regions of the United States, hospitalizations for
PQI conditions have declined in recent years [16]. Yet,
the impact of multimorbidity on utilization and cost is
relatively unknown. Such information could lead to im-
proved guidelines of care that address the complexities
of interacting conditions. Condition-specific data also
could allow for more targeted interventions on high-
cost, high-utilizing multimorbidity populations.
The purpose of this study was to evaluate how the
presence of MCCs relates to inpatient hospitalization
costs and utilization for sets of conditions that are po-
tentially preventable through high-quality ambulatory
care.
Methods
Data and study population
We used data from the 2012 AHRQ Healthcare Cost
and Utilization Project (HCUP) State Inpatient Data-
bases (SID) to carry out a cross-sectional analysis. In the
SID, we identified 1.43 million discharge records, repre-
senting 3.58 million (weighted) potentially preventable
hospitalizations. We selected a sub-sample of the SID,
the SID disparities analysis file, which is used to com-
pute national estimates for the National Healthcare
Disparities Report. It consists of weighted records from
a sample of hospitals from 38 States participating in
HCUP that have high-quality race/ethnicity data in
2012: AK, AR, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN,
KS, KY, MA, MD, MI, MO, NC, NJ, NM, NV, NY, OH,
OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI,
and WY. The SID disparities analysis file contains re-
cords representing 91 % of all U.S. hospital discharges.
Nationally-representative statistics were computed using
discharge weights that were constructed with consider-
ation of different attributes of the hospital, including the
number of beds, geographic region, number of dis-
charges and teaching status. We selected records for
U.S. adults aged 18 years and older discharged from U.S.
community, non-rehabilitation hospitals with a primary
diagnosis of an ambulatory care sensitive condition con-
tained within AHRQ PQIs. All investigators completed
training and signed a data use agreement for the HCUP
SID (https://www.hcup-us.ahrq.gov/tech_assist/dua.jsp).
Because data for our analyses did not involve human
subjects, IRB approval was not required. HCUP SID data
are available via the HCUP Central Distributor (https://
www.hcup-us.ahrq.gov/tech_assist/centdist.jsp).
We categorized hospitalizations into subsets based on
three PQIs focused on broad composites of potentially
preventable hospitalizations: the acute composite (PQI
91), the chronic composite (PQI 92), and the overall
composite (PQI 90). The acute composite (PQI 91) in-
cluded hospitalizations for dehydration, bacterial pneu-
monia, and urinary tract infection (n = 559,515). The
chronic composite (PQI 92) included hospitalizations for
diabetes (short-term complications, long-term complica-
tions, uncontrolled diabetes, and lower-extremity ampu-
tation for diabetes), chronic obstructive pulmonary
disease (COPD) or asthma in older adults, hypertension,
congestive heart failure, angina without a procedure, and
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asthma in younger adults (n = 866,668). The Overall
Composite (PQI 90) was the union of the three PQI 91
conditions and the nine PQI 92 conditions (n = 1,426,153).
Discharge records were scored using version 4.4 of
the AHRQ Quality Indicator SAS software to identify
hospital stays that fit the definitions of the PQI
composites [17].
Primary independent variable
Our primary independent variable was the number of
MCCs present in primary and secondary diagnosis
codes. We created categories of MCCs grouped as 0–1
condition, 2–3 conditions, 4–5 conditions, and 6+ con-
ditions from the list of conditions defined by the HHS
Strategic Framework [7, 18]. To be included in the
chronic PQI sample, patients had to have at least 1
chronic condition; therefore the “0–1 condition” refer-
ence category for these patients included those with
exactly 1 chronic condition, whereas patients with an
acute PQI were placed in the “0–1 condition” category if
they had either 0 or 1 concurrent chronic condition.
The 20 chronic conditions included were arthritis,
asthma, autism spectrum disorder, coronary artery dis-
ease (CAD), cancer, cardiac arrhythmias, chronic kidney
disease (CKD), congestive heart failure (CHF), COPD,
dementia, depression, diabetes, hepatitis, HIV, hyperlipid-
emia, hypertension, osteoporosis, schizophrenia, stroke,
and substance use disorders.
Covariates of interest
We selected patient population characteristics including
sex, age group (18–39 years, 40–64 years, 65+ years),
and race/ethnicity (White non-Hispanic, Black non-
Hispanic, Hispanic, Asian Pacific Islander non-Hispanic,
and Other). Race/ethnicity measures may be problematic
in hospital discharge databases because some states do
not collect information on race and ethnicity from hos-
pitals and, within states that collect the information,
some hospitals do not code race and ethnicity reliably.
To deal with this problem, we used the SID Disparities
Analysis File for 2012 designed for the AHRQ National
Healthcare Disparities Report to provide national accur-
ate estimates of race and ethnicity. A measure for race/
ethnicity in the SID is created using a stratified, weighted
sample of hospitals with good reporting of patient race and
ethnicity from 38 SID states: Alaska, Arizona, Arkansas,
California, Colorado, Connecticut, Florida, Georgia,
Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Maryland,
Massachusetts, Michigan, Missouri, Nevada, New Jersey,
New Mexico, New York, North Carolina, Ohio, Oklahoma,
Oregon, Pennsylvania, Rhode Island, South Carolina, South
Dakota, Tennessee, Texas, Utah, Vermont, Virginia,
Washington, Wisconsin, and Wyoming. It is drawn as
a hospital sample of 40 % of community, nonrehabilitation
hospitals in the United States (about 2000 hospitals) [19].
Additional patient circumstances explored in descriptive
analyses were patient location (largest locales [metropol-
itan and micropolitan] and smallest locales [nonmetropol-
itan and nonmicropolitan]) and primary expected source
of payment (private insurance, Medicare, Medicaid, other
insurance, uninsured [includes uninsured, self-pay, no
charge, and other])
Analytic methods
All analyses used discharge-level data rather than hospital-
level aggregates. Descriptive statistics were computed by
tabulating the number and percentage of discharges ob-
served in categories of MCCs and in categories of demo-
graphic characteristics of the sample for each set of
ambulatory care sensitive conditions (i.e., within each PQI
composite). We then developed multivariate models to
examine associations between categories of MCCs and the
three outcome variables: 1) inpatient costs per stay (dol-
lars), 2) inpatient costs per day (dollars per day), and 3)
length of inpatient hospitalization (days). As our data on
costs per stay and per day was over-dispersed, we used a
negative binomial 2 regression model to accommodate
this skewed cost data. We used generalized linear models
to model length of stay (LOS). Hospital costs were derived
by converting reported charges data to estimated costs
using hospital-specific cost-to-charge ratios contained in
the 2012 HCUP SID Cost-to-Charge Ratio files (https://
www.hcup-us.ahrq.gov/db/state/costtocharge.jsp#user).
All models included the primary independent variable,
number of MCCs. Zero or 1 chronic condition was the
reference category in multivariate analyses. We also con-
trolled for the population characteristics using males, 65
+ years of age, and White race/ethnicity as the reference
categories.
Because inpatient mortality could confound the rela-
tionship between cost and MCCs, we adjusted models to
assess whether findings were affected by discharge dis-
position. We used two indicators. The first indicator—
dead or alive—was tested in the inpatient hospital cost
per stay regression model. The second indicator used
eight discharge dispositions—home or self-care, transfer
to short-term hospital, transfer to other facility, home
health care, against medical advice, died in hospital, dis-
charged alive, and unknown or missing—to examine
other potential reasons for the longer LOS for patients
with MCCs.
Results
Descriptive results
A descriptive overview of the sample population charac-
teristics is provided in Table 1. Over half of patients dis-
charged in 2012 for ambulatory care sensitive conditions
Skinner et al. BMC Health Services Research  (2016) 16:77 Page 3 of 8
were 65 years or older. Likewise, Medicare was the most
prevalent primary expected payer (64 %), followed by
private insurance (16 %). The majority of patients were
female (56 %), were White Non-Hispanic (69 %), and re-
sided in a metropolitan area (91 %).
Among patients hospitalized for acute ambulatory care
sensitive conditions in 2012, only 22 % did not have
MCCs present (Table 1). The most common category
observed was 2 or 3 chronic conditions (38 % of pa-
tients), followed closely by those with 4 or 5 chronic
conditions (30 % of patients); 10 % of patients had 6 or
more chronic conditions. Patients who were hospitalized
for a potentially preventable chronic condition had a
higher number of MCCs than those with acute condi-
tions. The third category (4 or 5 chronic conditions) was
the most prevalent (39 % of stays), followed by the 2 or
3 chronic-condition category (31 % of stays). The highest
category of MCCs (6+ conditions) represented 23 % of
discharges among those hospitalized for an ambulatory
care sensitive chronic condition.
Multivariate regression results: costs
We examined inpatient hospitalization costs in relation
to the number of MCCs present adjusting for age, sex,
and race/ethnicity (Table 2). Compared with patients
with 0 or 1 chronic condition, total hospitalization costs
for ambulatory care sensitive conditions were 19 %
higher for those with 2 or 3 chronic conditions (95 %
confidence interval [CI] 1.19–1.20), 32 % higher for
those with 4 or 5 chronic conditions (95 % CI 1.31–
1.32), and 31 % higher for those with 6 or more chronic
conditions (95 % CI 1.30–1.32). We observed similar
patterns per hospitalization for potentially preventable
acute conditions: compared with patients with 0 or 1
chronic condition, relative costs were 14 % higher for
those with 2 or 3 conditions (95 % CI 1.14–1.15), 26 %
higher for those with 4 or 5 conditions (95 % CI 1.25–
1.27), and 33 % higher for those with 6+ conditions
(95 % CI 1.32–1.34). Among those hospitalized for po-
tentially preventable chronic conditions, inpatient costs
per stay were 23 % higher if 2 or 3 chronic conditions
were present (95 % CI 1.22–1.24), 33 % higher if 4 or 5
chronic conditions were present (95 % CI 1.32–1.34),
and 28 % higher if 6+ chronic conditions were present
(95 % CI 1.27–1.29)., compared with 0 or 1 chronic
condition. We adjusted models for mortality status at
discharge and saw very slight attenuation of these as-
sociations (Table 3).
Multivariate regression results: cost per day and LOS
We used two measures to evaluate cost per stay: cost
per day (intensity of daily care) and LOS (duration of
care). We examined how the number of MCCs was re-
lated to cost per day and LOS of stay for inpatient care
Table 1 Characteristics among inpatient hospital stays for
ambulatory care sensitive conditions included in the AHRQ PQIs
Characteristic Overall
composite
(PQI 90)
Acute
composite
(PQI91)
Chronic
composite
(PQI 92)
Discharges (n)
Total (weighted) 3,580,785 1,402,097 2,178,765
Mean cost per discharge (USD) $8085 $7551 $8431
Mean Length of Stay (days) 4.4 4.3 4.4
Discharges (%)
Without MCC (0–1 chronic condition) 13.2 21.8 7.7
2–3 chronic conditions 33.7 37.8 31.0
4–5 chronic conditions 35.3 30.1 38.7
6+ chronic conditions 17.8 10.2 22.6
Age (%)
18–39 years 8.9 8.9 8.9
40–64 years 33.2 26.7 37.5
65+ years 57.8 64.3 53.6
Sex (%)
Male 43.7 39.2 46.6
Female 56.3 60.8 53.4
Race/ethnicity (%)
White non-Hispanic 69.3 76.0 65.0
African American non-Hispanic 17.5 11.3 21.5
Hispanic (of any race) 9.2 8.7 9.5
API non-Hispanic 1.5 1.6 1.5
Other non-Hispanic 2.4 2.4 2.5
Patient location (%)
Metropolitan; micropolitan 90.7 89.1 91.7
Non-metro-; Non-micropolitan 9.3 10.9 8.3
Primary expected payer (%)
Private insurance 15.8 16.6 15.2
Medicare 63.8 67.2 61.6
Medicaid 11.4 8.8 13.0
Other insurance 2.5 2.2 2.7
Uninsured/self-pay/no charge 6.6 5.2 7.5
Discharge status
Missing 0.02 0.02 0.02
Home or self-care 61.32 58.08 63.41
Short-term hospital 2.02 1.71 2.22
Other type of facility 17.28 22.29 14.06
Home health care 16.05 14.86 16.82
Against medical advice 1.61 1.06 1.97
Died in hospital 1.65 1.94 1.47
Alive; destination unknown 0.04 0.04 0.04
Abbreviations: API Asian Pacific Islander, MCC multiple chronic condition, PQI
Prevention Quality Indicator
Source: Agency for Healthcare Research and Quality, Healthcare Cost and
Utilization Project, State Inpatient Databases, 2012
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(Table 3). Among hospitalizations for both acute and
chronic ambulatory care sensitive conditions, we did not
observe meaningful associations between the presence of
a higher number of MCCs and cost per day of
hospitalization. In contrast, we did observe positive asso-
ciations between the presence of more chronic condi-
tions and longer stays in the hospital.
In the acute composite group, compared with those
with 0 or 1 chronic condition, hospital stays were 11 %
longer when 2 or 3 chronic conditions were present
(95 % CI 1.11–1.12), 21 % longer when 4 or 5 conditions
were present (95 % CI 1.20–1.22), and 27 % longer when
6+ conditions were present (95 % CI 1.26–1.28). Simi-
larly, for the chronic composite group, the presence of 2
or 3 chronic conditions was associated with a 17 % lon-
ger stay (95 % CI 1.16–1.18), 4 or 5 chronic conditions
was associated with a 24 % longer stay (95 % CI 1.23–
1.25), and 6+ chronic conditions was associated with a
22 % longer stay (95 % CI 1.21–1.23) than those with
just 1 chronic condition. Our additional adjustment for
discharge status resulted in little change in the estimates,
although some attenuation was noted for the 6+ condi-
tion category in both the acute and chronic composite
groups (Table 3).
Table 2 Multivariable regressions of total inpatient hospital costs by MCCs category among ACSCs in the AHRQ PQIs
Overall composite (PQI 90) Acute composite (PQI 91) Chronic composite (PQI 92)
Total inpatient costsa Relative costs 95 % CI Relative costs 95 % CI Relative costs 95 % CI
Intercept (dollars per day) $6583 $6495 $6751
0–1 chronic condition 1.00 Ref. 1.00 Ref. 1.00 Ref.
2–3 chronic conditions 1.19 (1.19–1.20) 1.14 (1.14–1.15) 1.23 (1.22–1.24)
4–5 chronic conditions 1.32 (1.31–1.32) 1.26 (1.25–1.27) 1.33 (1.32–1.34)
6+ chronic conditions 1.31 (1.30–1.32) 1.33 (1.32–1.34) 1.28 (1.27–1.29)
Abbreviations: ACSC ambulatory care sensitive condition, CI confidence interval, MCC multiple chronic condition, PQI Prevention Quality Indicator
a Model adjusted for age, sex, race. Reference categories are 65+ years old, male, and white
Source: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, State Inpatient Databases, 2012
Table 3 Multivariable regressions of hospitalization costs per inpatient day and LOS by MCCs category among ACSCs in the
AHRQ PQIs
Overall composite (PQI 90) Acute composite (PQI 91) Chronic composite (PQI 92)
Costs per inpatient daya Relative costs 95 % CI Relative costs 95 % CI Relative costs 95 % CI
Intercept (dollars per day) $1937 $1896 2057
0–1 chronic condition 1.00 Ref. 1.00 Ref. 1.00 Ref.
2–3 chronic conditions 1.03 (1.03–1.03) 1.01 (1.00–1.01) 1.01 (1.01–1.02)
4–5 chronic conditions 1.05 (1.04–1.05) 1.01 (1.01–1.02) 1.02 (1.01–1.02)
6+ chronic conditions 1.04 (1.03–1.04) 1.01 (1.01–1.02) 0.99 (0.99–1.00)
Length of stay-Model 1a Relative stay 95 % CI Relative stay 95 % CI Relative stay 95 % CI
Intercept (Days) 3.88 3.86 3.86
0–1 chronic condition 1.00 Ref. 1.00 Ref. 1.00 Ref.
2–3 chronic conditions 1.13 (1.13–1.14) 1.11 (1.11–1.12) 1.17 (1.16–1.18)
4–5 chronic conditions 1.22 (1.22–1.23) 1.21 (1.20–1.22) 1.24 (1.23–1.25)
6+ chronic conditions 1.23 (1.22–1.23) 1.27 (1.26–1.28) 1.22 (1.21–1.23)
Length of stay-Model 2b Relative stay 95 % CI Relative stay 95 % CI Relative stay 95 % CI
Intercept (Days) 2.80 2.96 2.77
0–1 chronic condition 1.00 Ref. 1.00 Ref. 1.00 Ref.
2–3 chronic conditions 1.15 (1.15–1.16) 1.12 (1.11–1.13) 1.18 (1.17–1.20)
4–5 chronic conditions 1.24 (1.23–1.25) 1.20 (1.19–1.21) 1.24 (1.22–1.25)
6+ chronic conditions 1.22 (1.21–1.23) 1.25 (1.24–1.26) 1.18 (1.16–1.19)
Abbreviations: ACSC ambulatory care sensitive condition, CI confidence interval, LOS length of stay
a Model adjusted for age, sex, race
b Model adjusted for age, sex, race and discharge status
Source: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, State Inpatient Databases, 2012
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Discussion
Multiple chronic conditions are highly prevalent among
U.S. patients hospitalized for potentially preventable
acute and chronic conditions. In this study, more than
90 % of those hospitalized for ambulatory care sensitive
chronic conditions had 2 or more chronic conditions,
and over 20 % had 6 or more chronic conditions. For
those hospitalized for potentially preventable acute con-
ditions, nearly 80 % had MCCs and more than 10 % had
6 or more chronic conditions. This study’s findings on
prevalence are consistent with previously published lit-
erature on hospitalization trends for people with MCCs.
Other studies have reported higher utilization among
patients with more chronic conditions [6, 9, 20, 21]. A
study of 2009 HCUP discharge data showed that two-
thirds of hospitalized patients had MCCs [6]; by 2012
we found that 80–90 % of patients in our sample had
MCCs. Other studies have shown increasing rates of
MCCs in the United States [9].
The high prevalence of MCCs among hospital patients
indicates that we need better understanding and treat-
ment of these patients. What is the pattern of their use
of health care services across the care spectrum? Will
improving coordination of care, monitoring patient con-
ditions, and directing patients to more appropriate
health care settings result in better health outcomes and
greater efficiencies of utilization? HHS has developed a
strategic framework with goals of strengthening the U.S.
health care and public health systems, empowering indi-
viduals to use self-care management, equipping health care
providers with tools and interventions, and supporting tar-
geted research on MCCs to create effective interventions
[22]. For example, AHRQ has developed tools that physi-
cians can use to enhance ambulatory care for patients by
improving communication with patients, by encouraging
patients to obtain preventive services and to schedule eval-
uations and treatments on time, and by monitoring pa-
tients for medication effectiveness and adverse events,
among other evidence-based approaches [23].
Consistent with our inpatient cost results, other stud-
ies have shown higher inpatient health care costs for pa-
tients with MCCs [6, 11, 20]. Authors of a systematic
literature review of 35 studies found that almost all stud-
ies showed a positive monotonic relationship between
cost and MCCs [20]. For example, in a study on the im-
pact of MCCs among the Medicare population, annual
payment amounts per beneficiary for all settings of care
and for those with only 1, 2, and 3 or more conditions
were $7172, $14,931, and $32,498, respectively, in 2005
dollars [24]. In our study of inpatient costs for all payers
in 2012, costs per stay for the reference category, white
males 65 and older, were $6583, $7833, $8689, and
$8623 for 0 or 1, 2 or 3, 4 or 5, and 6 or more condi-
tions, respectively. In our study, the higher cost of
inpatient treatment was driven by longer lengths of stays
rather than by higher costs per day on average. This re-
sult suggests that patients admitted and initially treated
for one condition may require extra days for monitoring
and treatment of one or more of their secondary condi-
tions. For example, a patient admitted with hypertension
and diabetes might be managed quickly in terms of blood
pressure, but not in terms of blood glucose. Achieving a
reasonable glucose level may require extra days in the hos-
pital. Diabetes management and control would not require
large outlay costs, as a surgical intervention might, but
they would require a longer stay for treatment, for titra-
tion of medication, and for development of a suitable
post-discharge plan. Alternatively, the data may suggest
that individuals that present to the hospital with multiple
chronic conditions may have more severe complications
with their primary condition upon arrival at the hospital
that require greater lengths of stay. For example, an indi-
vidual with diabetes and depression that is admitted to a
hospital due to diabetic complications may, on average,
have a more severe complication and require longer stays
than, on average, an individual that is admitted to a hos-
pital with diabetic complications but has no other chronic
diseases. We note that the subgroup with 6 or more
chronic conditions has essentially the same costs as those
with 4 to 5 such conditions; the lack of a monotonically
increasing cost for the 6+ group suggests that additional
diagnostic coding, perhaps motivated by reimbursement,
does not add information about risk related to the cost of
a stay. Counting up to 5 or more chronic conditions may
be sufficient for profiling the relationship of chronic con-
ditions to utilization and outcomes.
One implication of our research is the potential value
from incorporating MCCs or numbers of MCCs into
risk adjustment, quality and performance measurement,
and other analytics. The statistically significant findings
that more MCCs result in longer hospital stays and
higher costs per stay suggest that the number of MCCs,
if not specific MCC combinations, should be analyzed
whenever severity of a patient’s condition is a potential
contributing factor to an outcome or a potential distin-
guishing feature of a population. The number of chronic
coexisting conditions typically is not used as a measure
of severity in health services research or performance
measurement, although particular comorbidities may be
specified in various risk adjustment schemes. Findings
from this study suggest that the number of MCCs could
be a simple and useful predictor of utilization and costs
of health care services that account for the complexity
of patients’ conditions. Furthermore, health policymakers
might test the effect of number of MCCs on reimburse-
ment formulas and provider performance measures to
create equitable comparisons and adjustments of pay-
ments among providers.
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Our study benefited from the use of the HCUP SID, a
large discharge database of experience for all payers. Use
of the PQI conditions facilitated examining MCCs for
patients who share potentially preventable conditions.
Despite these strengths, our results should be inter-
preted in light of their limitations. First, only a portion
of the total costs of care for chronic disease can be stud-
ied using hospital data. Although hospital stays account
for a large portion of the cost of some chronic condi-
tions such as heart failure, they do not include office
visits, clinical tests, drug therapy, and other ancillaries.
Second, only 38 of the 50 states provided data that could
be used for this study, so the study is not nationally rep-
resentative, despite over 3.5 million discharges for the 12
conditions reflected in the composite PQIs.. Third, vari-
ation in the presence of MCCs reflects only a portion of
the variability of hospital costs among patients in our
analysis. In particular, we did not address other patient,
hospital, and community factors that influence costs.
Our intent for this analysis was to explore the value of
future work on MCCs, which we confirmed. Fourth,
enumerating the number of chronic conditions present
in hospital records depends on the extent of coding of
secondary diagnoses in the data. To the extent that re-
cording may be truncated, the number of MCCs may
have been underestimated. In addition, our use of an
enumeration of chronic diseases, rather than incorporat-
ing measures of the severity of an individual’s illness,
such as the Charlson co-morbidity index [25], or a con-
sideration of each individuals specific disease combina-
tions based on their specific disease profile, as done by
Kadam and colleagues [26], prohibits us from identifying
which combinations of diseases are most strongly associ-
ated with the outcomes of interest. However, the enu-
meration and categorization of conditions aligns our
results with operating definitions of MCC outlined by
the United States Department of Health and Human
Services initiatives that underlie research and policy con-
siderations on this topic and does allow for a general un-
derstanding of MCCs that would not be possible
considering disease combinations in isolation.
Conclusions
In this large sample of records of U.S. hospitalizations,
we observed a positive association between the presence
of MCCs and hospitalization costs for potentially pre-
ventable conditions. The higher costs associated with
MCCs was driven by longer hospital stays rather than by
higher costs per day. To our knowledge, this is the first
study to examine MCC in relation to costs and length of
stay for hospitalizations that are potentially preventable
through high-quality ambulatory care. e. When consid-
ering trends in costs and utilization related to prevent-
able hospitalizations, studies have indicated that the
occurrence of preventable hospitalizations is decreasing
in the United States [8]. However, it is important to con-
sider that at the same time, the prevalence of patients
presenting with MCCs is increasing [6, 8]. The higher
costs and utilization associated with these more compli-
cated patients bring a greater burden with each prevent-
able hospitalization. Thus, although the number of
preventable hospitalizations is declining, our analyses
indicate that some of the benefit anticipated with that
reduction may be offset by an increase in costs and
utilization driven by a rise in the prevalence of MCCs.
Patients with MCCs are a challenge to treat because of
the number, complexity, and interaction of their ill-
nesses. Patients with a high number of morbidities may
be experiencing end-of-life crises that lead them to the
hospital repeatedly; recent insights on how the medical
profession deals with patients at the end of life suggest
that the health care system could benefit from educating
clinicians on how to deal with these situations realistic-
ally and humanely [27].
In this study we specifically examined the hospital ex-
perience, but treatment spans all settings of care. A
greater understanding of how MCCs influence care costs
and utilization from ambulatory care through the in-
patient setting may help providers across this spectrum
identify ways to work together to achieve optimum health
outcomes for their patients and to reduce hospitalization
costs [12].
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